SIROLLI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 7.102
EU - Europa 3.452
AS - Asia 3.308
Continente sconosciuto - Info sul continente non disponibili 914
SA - Sud America 348
AF - Africa 59
OC - Oceania 13
Totale 15.196
Nazione #
US - Stati Uniti d'America 6.842
SG - Singapore 1.229
CN - Cina 971
IT - Italia 683
IE - Irlanda 485
UA - Ucraina 460
SE - Svezia 365
RU - Federazione Russa 362
TR - Turchia 337
GB - Regno Unito 336
VN - Vietnam 282
BR - Brasile 272
DE - Germania 251
FR - Francia 223
IN - India 213
CA - Canada 133
FI - Finlandia 107
HK - Hong Kong 68
BD - Bangladesh 53
NL - Olanda 36
PL - Polonia 32
JP - Giappone 26
AR - Argentina 25
ES - Italia 22
MX - Messico 21
ZA - Sudafrica 21
BE - Belgio 20
CZ - Repubblica Ceca 19
IL - Israele 18
CR - Costa Rica 16
GT - Guatemala 15
TT - Trinidad e Tobago 15
AT - Austria 14
HN - Honduras 14
IQ - Iraq 13
AU - Australia 12
EC - Ecuador 12
ID - Indonesia 12
IR - Iran 11
CO - Colombia 9
EG - Egitto 9
JM - Giamaica 9
LT - Lituania 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
GP - Guadalupe 7
KR - Corea 7
VE - Venezuela 7
CL - Cile 6
EU - Europa 6
NI - Nicaragua 6
NP - Nepal 6
PY - Paraguay 6
TH - Thailandia 6
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
EE - Estonia 5
JO - Giordania 5
SV - El Salvador 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
NO - Norvegia 4
PR - Porto Rico 4
AL - Albania 3
BB - Barbados 3
CH - Svizzera 3
DK - Danimarca 3
KZ - Kazakistan 3
PA - Panama 3
TN - Tunisia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
HR - Croazia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SC - Seychelles 2
SN - Senegal 2
SO - Somalia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
Totale 14.281
Città #
Singapore 850
San Jose 727
Ashburn 595
Chandler 522
Jacksonville 518
Dublin 483
Houston 336
Dallas 306
Council Bluffs 262
Beijing 260
Los Angeles 234
Princeton 209
Southend 206
New York 167
Izmir 160
Nanjing 142
Chieti 139
Dearborn 125
Santa Clara 116
Ho Chi Minh City 86
Wilmington 83
Cambridge 81
Ann Arbor 77
Nanchang 75
San Francisco 70
Phoenix 65
The Dalles 65
Altamura 64
Hong Kong 62
Buffalo 61
Tongling 60
North Bergen 56
Orem 56
Hanoi 54
Denver 52
Atlanta 46
Boardman 43
Munich 42
Brooklyn 38
São Paulo 38
Woodbridge 37
Milan 34
Moscow 34
Montreal 33
Washington 33
Hebei 32
Shenyang 32
Chicago 30
Dong Ket 30
Pescara 28
Kunming 27
Warsaw 26
Rome 25
Tianjin 25
London 24
Redondo Beach 23
Tokyo 23
Boston 21
Jiaxing 21
Ottawa 20
Nuremberg 19
Brussels 18
Changsha 18
Helsinki 18
Stockholm 18
Amsterdam 17
Brno 17
Hefei 17
Jinan 17
Kocaeli 17
Toronto 17
Poplar 16
Chennai 15
Düsseldorf 15
Seattle 15
Johannesburg 14
Naples 14
Norwalk 14
Bologna 13
Columbus 13
Da Nang 13
Guatemala City 13
Haiphong 13
Hangzhou 13
Augusta 12
Paris 12
San José 12
San Mateo 12
Shanghai 12
Bari 11
Florence 11
Las Vegas 11
Leawood 11
Manchester 11
Philadelphia 11
Zhengzhou 11
Ardabil 10
Calgary 10
Catania 10
Kimball 10
Totale 8.740
Nome #
Treatment options for anemia in kidney transplant patients: a review 1.166
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 467
Quali soluzioni future per la dialisi peritoneale? 250
Plasma protein carbonylation in chronic uremia 217
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 210
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 207
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 193
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 190
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 182
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 182
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 181
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 181
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 176
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 176
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 173
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 170
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 170
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 169
Proteomics characterization of protein adsorption onto hemodialysis membranes 166
Proteomic Investigations into Hemodialysis Therapy 163
Biocompatibility of DIAPES 161
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 161
Effect of erythropoietin on primed leucocyte expression profile. 157
Urinary Peptidomic Biomarkers in Kidney Diseases 156
In vitro microbiology studies on a new peritoneal dialysis connector 155
Examining hemodialyzer membrane performance using proteomic technologies 155
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 151
Blood cell proteomics in chronic kidney disease 151
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 151
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 149
Update sull'impiego della proteomica in emodialisi 146
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 143
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 142
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 141
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 141
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 137
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 137
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 137
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 136
Removal of uremic plasma factors using different dialysis modalities 134
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 134
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 133
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 133
Uremic toxicity and anemia 131
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 131
Proteomic analysis of protein adsorption onto haemodialysis membranes 130
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 130
Use of oral hypoglycemic agents in patients with chronic kidney failure 129
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 127
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 127
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations 127
New treatment approaches for the anemia of CKD 125
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 125
L-carnitine in uremic anemia 125
Glomerulopathies associated with psoriasis: a report of three cases 124
Vascular inflammation in end-stage renal disease: the red blood cell connection 122
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 119
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 118
Management of IgA nephropathy 117
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 117
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 116
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 113
L'angiodisplasia gastroenterica nel paziente uremico in trattamento emodialitico regolare. Due casi clinici 112
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis 111
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 111
Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review 111
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report 110
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 110
Use of Proton Pump Inhibitors Is Not Associated with Post-Dialysis Fatigue and Time of Recovery after Dialysis in Patients on Maintenance Hemodialysis 109
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 106
Malattie renali cistiche 106
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 105
Surface Antigen Expression and Platelet Neutrophil Interactions in Haemodialysis 103
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes 103
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 102
Rene e paraproteine 102
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients 101
L’accesso vascolare negli anziani: prevenzione o spreco di risorse? 101
Nefropatie glomerulari familiari ed ereditarie 101
Proteomics and nephrology 100
Utilità di uno screening urinario in età scolastica 100
Prognosis of CKD patients receiving outpatient nephrology care in Italy 100
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 100
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 100
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review 100
Interactions between platelets and leukocytes during hemodialysis 99
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 96
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist 96
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 96
null 96
Rene e Gravidanza 96
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? 95
L’uremia batte…dove il dente duole!!! 93
Intensity, Duration, and Frequency of Post‐Dialysis Fatigue in Patients on Chronic Haemodialysis 89
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 87
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care 86
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 80
null 79
Post-dialysis fatigue and survival in patients on chronic hemodialysis 75
Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease 75
Totale 14.425
Categoria #
all - tutte 57.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022379 0 0 0 0 31 8 21 28 51 36 47 157
2022/20231.502 139 191 87 156 133 267 89 114 222 15 50 39
2023/2024812 59 20 58 32 41 280 167 30 4 20 19 82
2024/20251.762 114 246 203 90 46 71 43 84 264 74 223 304
2025/20264.926 333 158 331 443 374 207 717 213 416 371 1.243 120
2026/20271.244 63 167 239 545 230 0 0 0 0 0 0 0
Totale 15.196